Facebook Tracking Image

National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
NCCN Pfizer Axitinib Research Grant Opportunity: Submit by Wednesday, August 12, 2020
NCCN Pfizer Biosimilars Grant Opportunity - Submit by Wednesday, September 9, 2020
ORP Recent News
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
NCCN Shared Resources
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees
NCCN Policy Priorities

NCCN Research & Business Resources

Find a clinical trial >


The Vanderbilt-Ingram Cancer Center, home to two Nobel laureates, is an international leader in the cancer field, striving always toward its mission to alleviate cancer death and suffering through pioneering research; innovative, patient-centered care; and evidence-based prevention, education and community activities.

The center's work is based on core values of:

  • Discovery and innovation
  • Impact and translation
  • Relationships and collaboration
  • Service and compassion
Vanderbilt-Ingram is a National Cancer Institute-designated Comprehensive Cancer Center affiliated with Vanderbilt University Medical Center in Nashville, Tenn., and the only such center in Tennessee that conducts research and offers treatment for all types of adult and pediatric cancers. Led by Jennifer Pietenpol, Ph.D., the Center includes some 300 Vanderbilt faculty members in eight research programs. Together, these researchers and physician-scientists generate more than $140 million annually in research funding from federal and private sources. The Center currently ranks among the top 10 centers in both total grant support and the number of grants awarded annually by the National Cancer Institute. Vanderbilt is consistently listed by US News & World Report among the nation's best hospitals for cancer care. Vanderbilt University Medical Center is the only hospital in the region to be awarded Magnet Nursing Services Recognition from the American Nurses Credentialing Center.
Vanderbilt-Ingram's clinical enterprise offers access to some of the nation's foremost experts in cancer clinical care delivered with a multi-disciplinary approach. The Center's 180 clinicians see more than 5,000 new cancer patients each year. Particular strengths include colorectal, breast, lung, head and neck, neurologic, prostate and renal cancers; melanoma; sarcomas; leukemias, lymphomas and myelomas; survivorship and post-cancer wellness; and clinical trials.

In 2009, Vanderbilt established the REACH for Survivorship Program, a comprehensive survivorship program focused on the long-term physical, emotional and practical issues facing cancer survivors and family members. This clinic is Middle Tennessee's first and only dedicated cancer survivorship clinic that provides services for all cancer survivors, regardless of type of cancer, age at diagnosis, and where they received their cancer treatment. REACH for Survivorship also provides access to research to improve cancer survival and quality of that survivorship; patient and health care provider education; patient advocacy; and access to wellness and fitness programs.

Known for its focus on translational research and team science, Vanderbilt-Ingram has been awarded numerous multi-investigator grants involving researchers from a wide variety of disciplines. These include:
  • Two Specialized Programs of Research Excellence (SPOREs) in breast and gastrointestinal cancers
  • A Minority Partnership grant with Meharry Medical College and Tennessee State University dedicated to addressing health disparities and the needs of the underserved
  • A Center of Excellence in Precision Medicine and Population Health grant with Meharry Medical College and the University of Miami to enable research using precision medicine to eradicate health disparities, specifically those among African-Americans and Latinos.
The Center's team in population-based science and control focus on epidemiologic studies to better understand and address the causes of cancer through large cohorts including:
  • The Southern Community Cohort Study of 90,000 residents of the Southeastern United States, two-thirds of them African American
  • Large cohorts of men and women based in Shanghai

The Center's work is supported by a renowned biomedical informatics infrastructure at Vanderbilt University Medical Center, which also holds an NIH Clinical and Translational Science Award (CTSA) from the National Institutes of Health, designed to provide the infrastructure and resources needed to move discoveries quickly from the laboratory into clinical care.

Patients, referring provers and others: 615.936.8422 or (toll free) 877.936.8422
Searchable database of clinicians and health care providers: vanderbilthealth.com/ and click on “Doctor Directory”
Searchable database of cancer center members/researchers: vicc.org/dd/
Clinical trials information: Visit www.vicc.org and click on "Clinical Trials" or call 800.811.8480 or visit NCCN.org.